Metuchen Therapeutics, LLC - Mar 23, 2021 Form 4 Insider Report for Petros Pharmaceuticals, Inc. (PTPI)

Role: 10%+ Owner
Signature: [see signatures attached as Exhibit 99.1]
Stock symbol: PTPI
Transactions as of: Mar 23, 2021
Transactions value $: $0
Form type: 4
Date filed: 10/20/2021, 09:59 PM

Metuchen Therapeutics, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

(1) On March 23, 2021, Metuchen Therapeutics, LLC distributed all 273,213 shares of Common Stock held of record by MT to its respective members. As a result, the reporting person is no longer subject to Section 16 in connection with transactions in the equity securities of Petros Pharmaceuticals, Inc. and therefore will no longer report any such transactions on Form 4 or Form 5.